Biopharmaceutical
100 Most Popular
Pharmaceutical
AbbVie
$68.509876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$68.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.29 (0.42%) Today
-$0.04 (-0.06%) As of 7:19 PM EDT after-hours
Why Robinhood?
You can buy or sell AbbVie and other stocks, options, ETFs, and crypto commission-free!
About ABBV
ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. Read More The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Employees
30,000
Headquarters
North Chicago, Illinois
Founded
2011
Market Cap
101.32B
Price-Earnings Ratio
19.64
Dividend Yield
4.28
Average Volume
11.14M
High Today
$68.82
Low Today
$68.10
Open Price
$68.14
Volume
9.81M
52 Week High
$100.23
52 Week Low
$65.06
Collections
Biopharmaceutical
100 Most Popular
Pharmaceutical
Health
Manufacturing
Cancer Prevention
Technology
2013 IPO
ABBV News
Price Paid on Robinhood
22% Lower
Right Now
52 Week Low
$75.77
Average Price Paid
$87.55
52 Week High
$107.25
Analyst Ratings
36%
of 14 ratings
Buy
36%
Hold
57%
Sell
7%
ABBV Earnings
$1.44
$1.69
$1.95
$2.20
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
$2.20 per share
Actual
Available Jul 26, Pre-Market